Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense™ test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.
Looking for a particular Geneoscopy employee's phone or email?
Geneoscopy Questions
The Geneoscopy annual revenue was $18.6 million in 2026.
Andrew Barnell is the Co-Founder and Chief Executive Officer of Geneoscopy.
53 people are employed at Geneoscopy.
Geneoscopy is based in St. Louis, Missouri.
The NAICS codes for Geneoscopy are [32, 541714, 54171, 54, 325, 541, 5417].
The SIC codes for Geneoscopy are [28, 283, 87, 873].
Top Geneoscopy Employees
-
Andrew Barnell
Co-Founder and Chief Executive Officer at Geneoscopy
St. Louis, MO, US23 -
Amit Bhalla
Chief Financial Officer at Geneoscopy
New York, NY, US25+ -
Erica Barnell
Chief Medical Officer at Geneoscopy
St. Louis, MO, US32 -
24
-
Rachel Carbaugh
Vice President Human Resources at Geneoscopy
St. Louis, MO, US1 -
Matt Sargent
Chief Commercial Officer at Geneoscopy
Phoenix, AZ, US25+ -
Jackie Moriarty
Vice President of Market Access at Geneoscopy
San Francisco, CA, US22 -
Ryan Gorman
Vice President of Sales at Geneoscopy
Florida, United States25 -
23
-
Marshall Phares
Director of Finance at Geneoscopy
St. Louis, MO, US35+
Related Companies
